NovaDerm Aid Fund XII L.L.C. — Form D
NovaDerm Aid Fund XII L.L.C. of DALLAS, TX, a company, filed a Form D exempt-offering notice with the SEC on 2023-04-17. The offering totals $2.9M, of which $2.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-04-17
- Form: D
- Accession: 0001973995-23-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.9M
- Amount sold: $2.9M
- Minimum investment: $50K
- Investors: 21
- Date of first sale: 2022-12-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-479061
Issuer
- Name: NovaDerm Aid Fund XII L.L.C.
- CIK: 0001974001
- Entity type: Limited Liability Company
- Jurisdiction: NEVADA
- Incorporated: 2022
- Address: 4514 COLE AVENUE, SUITE 600, DALLAS, TX, 75205
- Phone: (214) 687-8437
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Biomed Management Alpha LLC | Director | DALLAS, TX |
| Geoffrey C Dietrich | Executive Officer | DALLAS, TX |
More